Determination of COVID-19 Vaccine Acceptance and Side Effects

Not yet recruiting

Lead Sponsor: Raghavendra Institute of Pharmaceutical Education and Research RIPERAutonomous

Brief Summary: The study is planned to conduct aftergetting approval from the Ethics committee (IRB, RIPER). Participants who met inclusion criteria willbe enrolled. A structured questionnaire comprising demographic information,including gender, region, religion, parenteral income, educationalqualification, occupation, attitude towards vaccination, and barriers of vaccineacceptance will be prepared. A Google form comprising of this questionnairewill be prepared and the link will be sent to the study participants to seekthe response. All responses of the participants will be recorded and analyzedto find statistical significance.

Recruitment & Eligibility

Inclusion Criteria

Population of age above 18 years of either sex and residents of Andhra Pradesh are included in the study.

Exclusion Criteria

Population with no internet facilities or androids and illiterates were excluded from the study.

Primary Outcome Measures

Name	Time	Method
This study aids in determining potential barriers for accepting COVID-19 vaccine.	3 months
This study will support in decreasing COVID-19 incidence rate in Andhra Pradesh.	3 months
This information helps in changing the public perspective regarding COVID-19 vaccine and related side effects.	3 months
This survey will assist the government and policy makers to create awareness in public for better vaccine acceptancy rate.	3 months

Secondary Outcome Measures

Name	Time	Method
To determine side effects encountered in vaccinated people	3 months

Locations (1): Raghavendra Institute of Pharmaceutical Education and Research RIPER Autonomous
🇮🇳
Anantapur, ANDHRA PRADESH, India
Raghavendra Institute of Pharmaceutical Education and Research RIPER Autonomous
🇮🇳Anantapur, ANDHRA PRADESH, India
Bhupalam Pradeepkumar
Principal investigator
9985968504
bhupalampradeep@gmail.com